Brookstone Capital Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-489
Closed -$8.42K 1206
2025
Q4
$8.42K Buy
+489
New +$9.48K ﹤0.01% 1162

Other funds holding AGL

Brookstone Capital Management's AGL Position: Q1 2026 in Review

Brookstone Capital Management sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 489 shares — an estimated $8.42K sold.

Brookstone Capital Management first reported a position in AGL in Q4 2025 and held it in 1 quarter. The position peaked at $8.42K in Q4 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Brookstone Capital Management reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
  • Brookstone Capital Management sold 489 Agilon Health shares in Q1 2026, an estimated $8.42K.
  • Brookstone Capital Management first reported a position in Agilon Health in Q4 2025 and held it in 1 quarter.
  • Brookstone Capital Management's Agilon Health position peaked at $8.42K in Q4 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Brookstone Capital Management's 13F filing for Q1 2026, filed 16 Apr 2026.